A Novel Multiplex Real-Time PCR Assay for the Detection of Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus 1/2 and Strategies for Application to Blood Screening.

Yushan Xu,Yan Lv,Mengjiao Lin,Miaomiao Li,Dawei Cui,Yongjun Wang,Cuifen Shen,Jue Xie
DOI: https://doi.org/10.1016/j.diagmicrobio.2024.116234
IF: 2.983
2024-01-01
Diagnostic Microbiology and Infectious Disease
Abstract:A multiplex real-time PCR has been developed to simultaneously detect transfusion-transmissible pathogens cytomegalovirus, Epstein-Barr virus and herpes simplex virus, as well as to provide sample quality testing, for the conserved regions of the cytomegalovirus UL123 gene, the Epstein-Barr virus BKRF1 gene, and the herpes simplex virus 1/2 UL30 gene, tested on 500 blood donors and 320 transfusion recipients. The laboratory sensitivities for all 3 pathogens were 100 copies/μL. Compared to the commercial real-time PCR reference kit, the multiplex real-time PCR assay for the detection of CMV, EBV and HSV presented 100% consistency. In 820 whole blood samples, the multiplex real-time PCR assay identified 34 (4.15%) positive for CMV DNA, 15 (1.83%) positive for EBV DNA, and 6 (0.73%) positive for HSV DNA. For blood transfusions in high-risk groups, whole blood herpes virus test should be included in the spectrum of pathogen testing for blood donors and recipients.
What problem does this paper attempt to address?